39.62
+0.21(+0.53%)
Currency In USD
| Previous Close | 39.41 |
| Open | 39.41 |
| Day High | 40.47 |
| Day Low | 38.73 |
| 52-Week High | 40.61 |
| 52-Week Low | 14.59 |
| Volume | 414,987 |
| Average Volume | 390,433 |
| Market Cap | 1.16B |
| PE | -90.05 |
| EPS | -0.44 |
| Moving Average 50 Days | 28.64 |
| Moving Average 200 Days | 21.97 |
| Change | 0.21 |
If you invested $1000 in Castle Biosciences, Inc. (CSTL) since IPO date, it would be worth $1,851.4 as of December 04, 2025 at a share price of $39.62. Whereas If you bought $1000 worth of Castle Biosciences, Inc. (CSTL) shares 5 years ago, it would be worth $761.92 as of December 04, 2025 at a share price of $39.62.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fifth Consecutive Year
GlobeNewswire Inc.
Nov 17, 2025 12:00 PM GMT
Castle also earns national recognition through three additional Top Workplaces Culture Excellence Awards — Employee Appreciation, Employee Well-Being and Professional DevelopmentFRIENDSWOOD, Texas, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Castle Bioscienc
New Data Confirms Performance of DecisionDx®-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity
GlobeNewswire Inc.
Nov 14, 2025 12:00 PM GMT
Second study to be presented at the 2nd European Congress on Dermato-Oncology demonstrates DecisionDx-Melanoma can identify patients with a negative sentinel lymph node who have a higher risk of poor outcomesFRIENDSWOOD, Texas, Nov. 14, 2025 (GLOBE
Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare Conference
GlobeNewswire Inc.
Nov 11, 2025 12:00 PM GMT
FRIENDSWOOD, Texas, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a comp